- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07570238
Effect of Gum Acacia and Electrolytes on Hydration After an Exercise-indued Dehydration (NEX/008624)
A Single-blinded, Placebo-controlled, Three-way Crossover Pilot Study, to Assess the Rehydrating Effect of a Nutritional Preparation Containing Gum Acacia Combined With Sea Magnesium After Exercise-induced Dehydration
This clinical study is a single-blind, placebo-controlled, three-way cross-over trial evaluating the rehydration efficacy of two nutritional beverages compared to water, after one administration. The investigational products are gum acacia alone, and combined with sea electrolytes as magnesium. Participants, physically active men undergo exercise-induced dehydration followed by controlled rehydration procedure with each product in randomized sequence. The study includes standardized preconditions (diet, hydration, activity control), exercise and rehydration protocols.
Gam acacia has the benefit of few preclinic studies in murin models showing significant improvements on electrolytes and water absorption, but its effect on hydration in human has never been evaluated.
The combination with sea electrolytes has been developed to optimise and reduce the total concentration of electrolytes into the beverage compared to standard formulations proposed for rehydration in sport application.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Damien Guillemet, MSc
- Telefonnummer: +33682422169
- E-mail: d.guillemet@nexira.com
Studiesteder
-
-
-
Berlin, Tyskland, 10369
- Analyze & Realize GmbH
-
Kontakt:
- Veronika Bobb
- E-mail: vbobb@a-r.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- BMI 18-25
- Regular physical training on a recreational level
- Resting pulse rate <100; resting blood pressure <140 mmHg/<100 mmHg
Exclusion Criteria:
- Participant suffering from acute or recently occurred (in the past 2 weeks) sickness e.g. common cold or gastrointestinal problems
- Injuries that would limit exercise performance
- History or presence of cardiovascular, metabolic, endocrine musculoskeletal, autoimmune or renal condition/disorder which per investigator's judgement could interfere with the results of the study or the safety of the participant
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Placebo komparator: Water
Provided to the participants in a blinded manner
|
On site prepared beverage to replenish 125% of body water loss during the standardized exercise
|
|
Eksperimentel: Gum Acacia (InaveaTM pure acacia) 8gr/L
Provided to the participants in a blinded manner
|
On site prepared beverage to replenish 125% of body water loss during the standardized exercise
|
|
Eksperimentel: Gum Acacia (InaveaTM pure acacia) 8gr/L + Sea electrolytes (SimagTM 15) 1.2gr/L
Provided to the participants in a blinded manner
|
On site prepared beverage to replenish 125% of body water loss during the standardized exercise
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Fluid retention (%)
Tidsramme: At rehydration phase directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
Percentage of fluid retained from start of rehydration phase (weight of beverage intake ; cumulative urine weight)
|
At rehydration phase directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Net fluid balance (ml)
Tidsramme: Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
Net fluid balance = cumulative beverage intake (mL) - cumulative urine volume (mL) - total body sweat loss during standardized exercise (mL)
|
Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
Beverage Hydration Index (BHI)
Tidsramme: At rehydration phase directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
BHI = cumulative urine after intake of the verum beverage / cumulative urine after intake of the placebo (water)
|
At rehydration phase directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
Bioelectrical impedance vector analysis (BIVA, L)
Tidsramme: At rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
Impedancemetry ; Total body water, Extracellular water (ECW), Intracellular water (ICW), Ratio for ICW/ECW
|
At rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
Urine osmolality (mosmol/kg)
Tidsramme: Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
|
Urine Specific Gravity (USG)
Tidsramme: Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
|
Urine volume (mL)
Tidsramme: Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
(calculated from urine weight and USG)
|
Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
Blood Haemoglobin (g/dL)
Tidsramme: Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
|
Blood Haematocrit (%)
Tidsramme: Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
|
Plasma volume (%)
Tidsramme: Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
calculated from Hemoglobin (g/dL) and Hematocrit (%) according to Dill and Costill 1974
|
Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
Change in body weight (kg)
Tidsramme: At rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
from the end of standardized exercise
|
At rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
Body mass restored (%)
Tidsramme: At rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
from start of standardized exercise
|
At rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
Thirst perception (VAS)
Tidsramme: Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
100mm scale
|
Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
Gastro-Intetsainl symptoms (VAS)
Tidsramme: Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
100mm scale ; Nausea, Cramps, Bloating, Borborygmi, Flatus
|
Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
Global evaluation of tolerability (4 scales ; very good to poor)
Tidsramme: At 240 minutes
|
From participant, from investigator
|
At 240 minutes
|
|
Bioelectrical impedance vector analysis ratio (ICW/ECW)
Tidsramme: At rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
Impedancemetry ; Intracellular water (ICW) / Extracellular water (ECW)
|
At rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
Electrolytes in urine (mmol/L)
Tidsramme: At rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
Sodium, Potassium, Chloride, Magnesium, Calcium
|
At rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
|
Electrolytes in blood (mmol/L)
Tidsramme: Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
Sodium, Potassium, Chloride, Magnesium, Calcium
|
Before exercise / at rehydration phase before and directly after beverage intake (T0) / at 60 minutes / at 120 minutes / at 180 minutes / at 240 minutes
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- FIB12
- Eth-SB-26-023 (Anden identifikator: Ethik-Kommission der Ärztekammer Berlin (Germany))
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Sund voksen mand
-
Istanbul Medipol University HospitalAfsluttetMal de Debarquement Syndrome (MdDS)Tyrkiet (Türkiye)
-
Icahn School of Medicine at Mount SinaiNational Institute on Deafness and Other Communication Disorders (NIDCD)AfsluttetMal de Debarquement Syndrome (MdDS)Forenede Stater
-
Icahn School of Medicine at Mount SinaiNew York University; National Institute on Deafness and Other Communication... og andre samarbejdspartnereRekruttering
-
University of MinnesotaAfsluttetMal de Debarquement syndromForenede Stater
-
Al-Azhar UniversityAfsluttetSucces med adult pulpotomi hos patienter med diabetesEgypten
-
Mostafa BahaaSahar El-Haggar, Prof Clinical pharmacy Department- Tanta University; Principal... og andre samarbejdspartnereRekruttering
-
University of MinnesotaTrukket tilbageMal de Debarquement syndrom
-
University of MinnesotaTrukket tilbageMal de Debarquement syndromForenede Stater
-
Moataz Sleem Ahmed AliIkke rekrutterer endnu
-
Banaras Hindu UniversityInstitute of Medical Sciences of the Banaras Hindu University (BHU),IndiaAfsluttetGrand Mal Status Epilepticus
Kliniske forsøg med Rehydration beverage
-
Paul A BreslinThe Gerber FoundationRekrutteringAkut gastroenteritisForenede Stater
-
Guangzhou Blood CenterAfsluttet
-
Kansai Hepatobiliary Oncology GroupAfsluttet